NYSEAMERICAN:ELMD - Electromed Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $18.00
  • Forecasted Upside: 57.21 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$11.45
▼ -0.29 (-2.47%)

This chart shows the closing price for ELMD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Electromed Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ELMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ELMD

Analyst Price Target is $18.00
▲ +57.21% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Electromed in the last 3 months. The average price target is $18.00, with a high forecast of $21.00 and a low forecast of $15.00. The average price target represents a 57.21% upside from the last price of $11.45.

This chart shows the closing price for ELMD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 contributing investment analysts is to buy stock in Electromed.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/9/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/9/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/7/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/5/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/3/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/4/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/3/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/2/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/25/2021Northland SecuritiesReiterated RatingBuy
3/8/2021Colliers SecuritiesReiterated RatingBuy$21.00
11/24/2020Northland SecuritiesInitiated CoverageOutperform$15.00
11/11/2020Colliers SecuritiesReiterated RatingBuy
11/1/2019Dougherty & CoReiterated RatingBuy
10/18/2019Dougherty & CoInitiated CoverageBuy$12.00
(Data available from 8/3/2016 forward)
Electromed logo
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Read More

Today's Range

Now: $11.45
Low: $11.45
High: $11.68

50 Day Range

MA: $9.91
Low: $9.48
High: $10.28

52 Week Range

Now: $11.45
Low: $8.10
High: $18.69

Volume

16,778 shs

Average Volume

64,772 shs

Market Capitalization

$98.87 million

P/E Ratio

30.95

Dividend Yield

N/A

Beta

0.63

Frequently Asked Questions

What sell-side analysts currently cover shares of Electromed?

The following Wall Street analysts have issued reports on Electromed in the last twelve months: Colliers Securities, Northland Securities, and Zacks Investment Research.
View the latest analyst ratings for ELMD.

What is the current price target for Electromed?

2 Wall Street analysts have set twelve-month price targets for Electromed in the last year. Their average twelve-month price target is $18.00, suggesting a possible upside of 57.2%. Colliers Securities has the highest price target set, predicting ELMD will reach $21.00 in the next twelve months. Northland Securities has the lowest price target set, forecasting a price of $15.00 for Electromed in the next year.
View the latest price targets for ELMD.

What is the current consensus analyst rating for Electromed?

Electromed currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ELMD will outperform the market and that investors should add to their positions of Electromed.
View the latest ratings for ELMD.

What other companies compete with Electromed?

How do I contact Electromed's investor relations team?

Electromed's physical mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider's listed phone number is +1-952-7589299 and its investor relations email address is [email protected] The official website for Electromed is smartvest.com.